Literature DB >> 24920735

Renal neurohormonal regulation in heart failure decompensation.

Sofia Jönsson1, Mediha Becirovic Agic1, Fredrik Narfström2, Jacqueline M Melville1, Michael Hultström3.   

Abstract

Decompensation in heart failure occurs when the heart fails to balance venous return with cardiac output, leading to fluid congestion and contributing to mortality. Decompensated heart failure can cause acute kidney injury (AKI), which further increases mortality. Heart failure activates signaling systems that are deleterious to kidneys such as renal sympathetic nerve activity (RSNA), renin-angiotensin-aldosterone system, and vasopressin secretion. All three reduce renal blood flow (RBF) and increase tubular sodium reabsorption, which may increase renal oxygen consumption causing AKI through renal tissue hypoxia. Vasopressin contributes to venous congestion through aquaporin-mediated water retention. Additional water retention may be mediated through vasopressin-induced medullary urea transport and hyaluronan but needs further study. In addition, there are several systems that could protect the kidneys and reduce fluid retention such as natriuretic peptides, prostaglandins, and nitric oxide. However, the effect of natriuretic peptides and nitric oxide are blunted in decompensation, partly due to oxidative stress. This review considers how neurohormonal signaling in heart failure drives fluid retention by the kidneys and thus exacerbates decompensation. It further identifies areas where there is limited data, such as signaling systems 20-HETE, purines, endothelin, the role of renal water retention mechanisms for congestion, and renal hypoxia in AKI during heart failure.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  ADHF; GFR; acute renal failure; cardiorenal syndrome; glomerular filtration rate

Mesh:

Substances:

Year:  2014        PMID: 24920735     DOI: 10.1152/ajpregu.00178.2014

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  9 in total

Review 1.  A multidimensional sight on cardiac failure: uncovered from structural to molecular level.

Authors:  Vijay Urmaliya; Gustavo Franchelli
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

2.  Sympathoexcitation in Rats With Chronic Heart Failure Depends on Homeobox D10 and MicroRNA-7b Inhibiting GABBR1 Translation in Paraventricular Nucleus.

Authors:  Renjun Wang; Qian Huang; Rui Zhou; Zengxiang Dong; Yunfeng Qi; Hua Li; Xiaowei Wei; Hui Wu; Huiping Wang; Christopher S Wilcox; Michael Hultström; Xiaofu Zhou; En Yin Lai
Journal:  Circ Heart Fail       Date:  2015-12-23       Impact factor: 8.790

3.  Elevated copeptin, arterial stiffness, and elevated albumin excretion in adolescents with type 1 diabetes.

Authors:  Pattara Wiromrat; Petter Bjornstad; Carissa Vinovskis; Linh T Chung; Carlos Roncal; Laura Pyle; Miguel A Lanaspa; Richard J Johnson; David Z Cherney; Tyler K Reznick-Lipina; Franziska Bishop; David M Maahs; Raj Paul Wadwa
Journal:  Pediatr Diabetes       Date:  2019-08-29       Impact factor: 4.866

Review 4.  How cardiomyocytes sense pathophysiological stresses for cardiac remodeling.

Authors:  Zaffar K Haque; Da-Zhi Wang
Journal:  Cell Mol Life Sci       Date:  2016-10-06       Impact factor: 9.261

Review 5.  High serum creatinine nonlinearity: a renal vital sign?

Authors:  Carlos E Palant; Lakhmir S Chawla; Charles Faselis; Ping Li; Thomas L Pallone; Paul L Kimmel; Richard L Amdur
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-18

6.  G Protein-Coupled Receptor-G-Protein βγ-Subunit Signaling Mediates Renal Dysfunction and Fibrosis in Heart Failure.

Authors:  Fadia A Kamal; Joshua G Travers; Allison E Schafer; Qing Ma; Prasad Devarajan; Burns C Blaxall
Journal:  J Am Soc Nephrol       Date:  2016-06-13       Impact factor: 10.121

7.  Steroidogenic acute regulatory protein/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy.

Authors:  Wei-Wei Zhang; Rong-Hua Zheng; Feng Bai; Katelyn Sturdivant; Ning-Ping Wang; Erskine A James; Himangshu S Bose; Zhi-Qing Zhao
Journal:  Mol Biol Rep       Date:  2019-12-09       Impact factor: 2.316

Review 8.  Insights of Worsening Renal Function in Type 1 Cardiorenal Syndrome: From the Pathogenesis, Biomarkers to Treatment.

Authors:  Kang Fu; Yue Hu; Hui Zhang; Chen Wang; Zongwei Lin; Huixia Lu; Xiaoping Ji
Journal:  Front Cardiovasc Med       Date:  2021-12-14

Review 9.  Cardiorenal Syndrome: Role of Arginine Vasopressin and Vaptans in Heart Failure.

Authors:  Poornima Vinod; Vinod Krishnappa; Abigail M Chauvin; Anshika Khare; Rupesh Raina
Journal:  Cardiol Res       Date:  2017-06-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.